Test Price
2,800 AED✅ Home Collection Available
FOXC1 Gene Sequencing for Axenfeld-Rieger Syndrome Type 3 – NGS Molecular Diagnosis
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified next-generation sequencing (NGS).
Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM–11 PM.
Clinical Guidance: Telephonic post-test clinical guidance by DHA-licensed Consultant Medical Genetics.
Direct Billing: WhatsApp verification at +971 54 548 8731 for insurance coverage.
Test Overview & Methodology
The FOXC1 gene NGS test detects pathogenic variants in the FOXC1 gene responsible for Axenfeld-Rieger syndrome type 3, a condition affecting eye development and systemic abnormalities. This comprehensive sequencing is performed on peripheral whole blood or extracted DNA, with results delivered in 3–4 weeks.
| Feature | Our Test (NGS Full Gene Sequencing) | Alternative (Sanger Single Variant) |
|---|---|---|
| Precision | >99.9% detection of all coding variants | ~99% for targeted known mutation only |
| Methodology | NGS with coverage >200x | Sanger sequencing |
| Turnaround Time | 3–4 weeks | 2–3 weeks |
| Clinical Utility | Comprehensive; identify novel mutations | Confirm known familial variant only |
Physician Insight & Safety Protocols
“Every parent’s concern deserves cutting-edge clarity. This FOXC1 gene test provides the molecular diagnosis to guide early ophthalmologic and systemic interventions. Our team ensures that every report is correlated with your child’s clinical findings, because genetic information is only powerful when interpreted by an experienced specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory – Medication and Treatment Continuity
Results from this genetic test do not constitute a direct medical order to alter or discontinue any ongoing therapy. You must not stop prescribed medication without explicit guidance from your treating physician. Always consult your doctor before making changes to your child’s treatment regimen.
Exclusion Criteria & Safety Precautions
- Informed Consent: Testing of minors requires legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability; testing without authorization is prohibited.
- Sample Collection Contraindications: Patients with active coagulopathy (e.g., hemophilia) must be cleared by their treating physician before venipuncture.
- Recent Transfusion: Wait at least 2 weeks after allogeneic blood transfusion to avoid donor DNA interference.
- Emergency Red Flags: If the child experiences sudden vision loss, acute eye pain, or signs of elevated intracranial pressure, seek immediate emergency care rather than proceeding with elective genetic testing.
Patient FAQ & Clinical Guidance
1. What is the purpose of the FOXC1 gene Axenfeld-Rieger syndrome type 3 NGS test?
This test sequences your FOXC1 gene to identify mutations causing Axenfeld-Rieger syndrome type 3 for a definitive molecular diagnosis. It examines all coding regions using next-generation sequencing, guiding ophthalmologic care and genetic counselling.
2. How should I prepare my child for sample collection?
No special preparation required; the phlebotomist collects a small blood sample during our VIP home visit. Keep your child well-hydrated (unless medically discouraged) and bring relevant medical records.
3. When will I receive results and how are they explained?
Results are ready in 3–4 weeks and include a clinical interpretation call with a DHA-licensed Consultant Medical Genetics. You will receive a comprehensive report highlighting any disease-causing variants, with explanation of implications for your child’s health and family.
UAE Regulatory & Data Privacy Adherence
Data Protection: This genetic test is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic data is secured, processed with explicit consent, and stored in UAE-based infrastructure.
Clinical & Logistical Metadata
| Test Name | FOXC1 Gene Sequencing for Axenfeld-Rieger Syndrome Type 3 (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood or extracted DNA (EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with coverage >200x |
| ICD-10-CM Code | Q13.81 |
| LOINC Code | 21655-8 |
| DHA Facility License & Laboratory Address |
License No. 1143 DNA Labs UAE Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians